Delivery Order #SPE2DR26F7QEF

Delivery Order to AmerisourceBergen for Ondansetron Medication Supply

This award represents a delivery order contract under a larger indefinite delivery vehicle (IDV) with AmerisourceBergen Drug Corporation, a leading pharmaceutical wholesaler. The contract procures Ondansetron HCL 4 MG/2 ML Vials, a crucial medication used primarily to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, or surgery. The significance of this award is embedded in its support for federal healthcare facilities, ensuring they have timely access to essential medications that improve patient care outcomes. The scope covers the supply and delivery of specific pharmaceutical vials to a designated location in Pennsylvania within a short, defined period. This contract operates under the existing IDV contract vehicle, streamlining procurement efficiency. The award appears to be a continuation of ongoing drug distribution services to federal entities, emphasizing reliable pharmaceutical availability. This delivery order was issued without indications of competitive bidding details but supports ongoing government healthcare initiatives. The timeline for performance is concise, spanning a few days in early March 2026.

Description

4571053376!ONDANSETRON HCL 4 MG/2 ML VIAL 2ML

View original record